Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of topical lestaurtinib (CEP-701) cream in psoriasis vulgaris
2008-002317-40Phase 2Completed
- Sponsor
- Perrigo
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lestaurtinib in plaque psoriasis and psoriasis (4 arms), sponsored by Perrigo. Primary endpoint: Change from baseline in local PASI. Started Aug 2008; status: completed.
02
Drugs
lestaurtinib
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on 2008-002317-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002317-40.